AQST vs AZN · rev $28.3M vs P/E 28, $288.38B cap
Aquestive Therapeutics Inc (AQST) versus AstraZeneca PLC (AZN) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
AZN does not have a complete income-statement cache yet.
AQST currently screens at market cap $493.0M. AZN currently screens at market cap $288.38B and trailing P/E 28.0.
Not investment advice. Open the AQST and AZN stock pages for the full models.
Not investment advice.